IDSA and its HIVMA support the Biden Administration’s call for new global commitments to control the COVID-19 pandemic and applaud the Administration’s initial steps of donating vaccine doses and making financial contributions to COVAX, the COVID-19 Vaccines Global Access initiative.
IDSA is encouraged by today’s announcement from the Biden Administration on the allocation of more than $2 billion of American Rescue Plan funds to support infection prevention and efforts to combat antimicrobial resistance.
IDSA has expressed support for several proposed revisions to The Joint Commission’s antibiotic stewardship requirements for hospitals, while also providing additional recommendations to ensure the changes align with the Society’s strategic priorities.
IDSA supports President Biden’s multi-pronged approach to boost vaccination rates and strengthen our COVID-19 response. With COVID-19 cases on the rise and health systems stretched to capacity, it is imperative to public health and safety that eligible people get vaccinated.
IDSA is urging school systems nationwide to use all available public health tools and strategies to prevent COVID-19 transmission in schools as teachers and students return to in-person learning.
The FDA’s full approval of the Pfizer-BioNTech COVID-19 vaccine marks a pivotal milestone in the nation’s quest to control the effects of this pandemic. This approval is the culmination of intense, collaborative scientific research. The FDA’s announcement gives people who have not yet taken the vaccine additional assurance that this vaccine is safe and effective.
IDSA appreciates that HHS is planning to provide vaccinated people with a supplemental dose of vaccines if the FDA and CDC recommend a supplemental dose following a thorough and transparent evaluation of the evidence.
IDSA supports the FDA and CDC’s decision to authorize a supplemental vaccine dose for immunocompromised patients. This authorization will provide more protection for those who are at risk of serious COVID-19 illness and disease.
Increasing confidence in COVID-19 vaccines and uptake in these communities requires a creative, flexible and nimble approach that addresses the diverse concerns and barriers to vaccine access that people may have, according to a new article in Open Forum Infectious Diseases.
Pregnant individuals and those planning to become pregnant should feel confident in choosing vaccination to protect themselves, their infants, their families, and their communities.
A new Clinical Infectious Diseases supplement collects eight papers that have informed the scientific underpinning of essential nonbiological interventions used in the public health response to COVID-19.
As scientific and political leaders commemorate World Hepatitis Day, infectious diseases professionals call on policymakers to support the updated National Viral Hepatitis Strategic Plan that aims to eliminate viral hepatitis as a public health threat in the United States.